|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 184.05 DKK | -1.84% |
|
+0.60% | -3.27% |
| Jul. 13 | Bavarian Nordic's Partner Seeks Marketing Authorization for Chikungunya Vaccine in Brazil | MT |
| Jul. 13 | Bavarian Nordic Seeks Approval for Chikungunya Vaccine in Brazil | FW |
Company Valuation: Bavarian Nordic A/S
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 18,904 | 15,064 | 13,830 | 14,877 | 14,938 | 14,316 | - | - |
| Change | - | -20.32% | -8.19% | 7.57% | 0.41% | -4.16% | - | - |
| Enterprise Value (EV) 1 | 16,160 | 13,341 | 11,979 | 12,717 | 11,617 | 10,363 | 9,180 | 7,934 |
| Change | - | -17.44% | -10.21% | 6.15% | -8.64% | -10.8% | -11.41% | -13.58% |
| P/E | -36.3x | -43.6x | 9.24x | 15x | 10.8x | 21.8x | 20.9x | 16.3x |
| PBR | 2.57x | 2.1x | 1.34x | 1.31x | 1.18x | 1.12x | 1.06x | 0.99x |
| PEG | - | 1.3x | -0x | -0.4x | 0.3x | -0.4x | 4.64x | 0.6x |
| Capitalization / Revenue | 9.96x | 4.78x | 1.96x | 2.6x | 2.39x | 2.58x | 2.57x | 2.4x |
| EV / Revenue | 8.51x | 4.23x | 1.7x | 2.22x | 1.86x | 1.86x | 1.65x | 1.33x |
| EV / EBITDA | 216x | 40.7x | 4.58x | 7.93x | 4.57x | 6.75x | 5.84x | 4.38x |
| EV / EBIT | -51.6x | -188x | 5.81x | 13.5x | 6.44x | 12.4x | 10.6x | 7.18x |
| EV / FCF | -19.2x | -94.5x | 12.3x | 6.81x | 4.62x | 7.26x | 7.76x | 6.37x |
| FCF Yield | -5.21% | -1.06% | 8.15% | 14.7% | 21.7% | 13.8% | 12.9% | 15.7% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -7.4 | -4.9 | 19.2 | 12.6 | 17.6 | 8.598 | 8.985 | 11.5 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,898 | 3,151 | 7,062 | 5,716 | 6,244 | 5,557 | 5,563 | 5,969 |
| EBITDA 1 | 74.8 | 328 | 2,615 | 1,603 | 2,542 | 1,535 | 1,572 | 1,811 |
| EBIT 1 | -312.9 | -70.78 | 2,060 | 939.8 | 1,804 | 836.3 | 862.3 | 1,104 |
| Net income 1 | -464.8 | -347.4 | 1,475 | 988 | 1,375 | 672 | 699.3 | 900.4 |
| Net Debt 1 | -2,745 | -1,723 | -1,850 | -2,160 | -3,320 | -3,953 | -5,136 | -6,382 |
| Reference price 2 | 268.80 | 213.40 | 177.45 | 189.35 | 190.85 | 187.50 | 187.50 | 187.50 |
| Nbr of stocks (in thousands) | 70,329 | 70,589 | 77,937 | 78,567 | 78,270 | 76,352 | - | - |
| Announcement Date | 3/4/22 | 3/2/23 | 3/6/24 | 3/5/25 | 3/12/26 | - | - | - |
1DKK in Million2DKK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 21.81x | 1.86x | 6.75x | - | 2.19B | |
| 34.75x | 12.42x | 25.87x | 0.58% | 1,043B | |
| 26.86x | 6.13x | 16.78x | 2.15% | 602B | |
| 33.14x | 7.52x | 15.43x | 2.7% | 449B | |
| 17.71x | 4.39x | 10.82x | 3.02% | 327B | |
| 21.31x | 5.47x | 13.24x | 2.89% | 279B | |
| 21.26x | 4.48x | 12.39x | 1.96% | 264B | |
| 24.37x | 6.42x | 11.35x | 2.71% | 201B | |
| -49.1x | 5.86x | 32.41x | 2.38% | 169B | |
| 12.77x | 3.12x | 7.88x | 6.86% | 143B | |
| Average | 16.49x | 5.77x | 15.29x | 2.81% | 347.93B | |
| Weighted average by Cap. | 23.88x | 7.73x | 18.23x | 2.11% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- BAVA Stock
- Valuation Bavarian Nordic A/S
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
